CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy Chief Science/Medical Officer bought 7,937 shares at $0.63 ($5,000)
- 4 Open-market buy CFO bought 15,873 shares at $0.63 ($10,000)
- 4 Open-market buy CEO, President bought 72,464 shares at $0.69 ($50,000)
- 4 Open-market buy CEO, President bought 200,000 shares at $0.50 ($100,000)
- 4 Open-market buy Director bought 15,750 shares at $2.21 ($34,808)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Sr VP of Operations bought 8,014 shares at $0.46 ($3,686)
- 4 Open-market buy Chief Science/Medical Officer bought 9,892 shares at $0.46 ($4,550)
- 4 Open-market buy Sr VP of Operations bought 8,014 shares at $0.46 ($3,686)
- 4 Open-market buy CFO bought 6,981 shares at $0.46 ($3,211)
- 4 Open-market buy CEO, President bought 68,493 shares at $0.73 ($50,000)
- 4 Open-market buy CEO,President bought 10,000 shares at $1.00 ($10,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 31 · 616 filings